Efficacy of abciximab, despite patient weight, using lower heparin dosing during percutaneous coronary intervention - Aguirre, F A; Talley, D J; Ferguson, J J, III; Tcheng, J; Kleiman, N S; Montague, E A; Booth, J E; Lincoff, A M (Circulation, 1996)
(Suppl.)